Literature DB >> 8302934

Construction of a shuttle vector for use between Pasteurella multocida and Escherichia coli.

M M Bills1, J M Medd, R J Chappel, B Adler.   

Abstract

The isolation of a small plasmid from Pasteurella multocida has enabled the construction of a shuttle vector for use between P. multocida and Escherichia coli. The vector pBAC64 contains the origin of replication from P. multocida, an antibiotic resistance gene which functions in P. multocida, and the E. coli vector pUC18. The presence of the pUC18 multiple cloning site together with the lacZ' gene provides a screening method and allows cloning and manipulation in E. coli as well as cloning in P. multocida.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8302934     DOI: 10.1006/plas.1993.1058

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  5 in total

1.  Construction of in-frame aroA deletion mutants of Mannheimia haemolytica, Pasteurella multocida, and Haemophilus somnus by using a new temperature-sensitive plasmid.

Authors:  Fred M Tatum; Robert E Briggs
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

2.  Is the production of a Covid-19 vaccine using transformed Pasteurella plausible?

Authors:  Andrew N Rycroft; Ken C Smith; Rob Noad; Dirk Werling
Journal:  Vet Rec       Date:  2020-06-26       Impact factor: 2.695

3.  In vivo-expressed genes of Pasteurella multocida.

Authors:  M L Hunt; D J Boucher; J D Boyce; B Adler
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 4.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Is the production of a Covid-19 vaccine using transformed Pasteurella plausible?

Authors:  Andrew N Rycroft; Ken C Smith; Rob Noad; Dirk Werling
Journal:  Vet Rec       Date:  2020-07       Impact factor: 2.560

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.